A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. - Wikidata - awgldk - TriplyDB

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

http://www.wikidata.org/entity/Q34974010

about

Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview Aspirin, cyclooxygenase inhibition and colorectal cancer Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?Molecular cancer prevention: Current status and future directions A systematic review of aspirin in primary prevention: is it time for a new approach?Chemoprevention of cancer: current evidence and future prospects Chemoprevention in familial adenomatous polyposis The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism A multi-targeted approach to suppress tumor-promoting inflammation Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions.Role of inflammation and inflammatory mediators in colorectal cancer Attenuated familial adenomatous polyposis manifests as autosomal dominant late-onset colorectal cancer.Chemoprevention in patients with genetic risk of colorectal cancers Familial colon cancer syndromes: an update of a rapidly evolving field Colorectal cancer stem cells and their implications for novel anticancer therapy.Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study Aspirin and familial adenomatous polyposis: coming full circle Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancer Aspirin for the prevention of colorectal cancer Screening and Health Behaviors among Persons Diagnosed with Familial Adenomatous Polyposis and Their Relatives.Are we ready to recommend aspirin for cancer prevention?Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.Mechanistic aspects of COX-2 expression in colorectal neoplasia NSAIDs and Colorectal Cancer Control: Promise and Challenges An inflammatory mediator, prostaglandin E2, in colorectal cancer.Chemoprevention of gastrointestinal cancer: the reality and the dream.The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.Mechanistic and pharmacological issues of aspirin as an anticancer agent.Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large-bowel mucosa of healthy individuals.Prevention and intervention trials for colorectal cancer.Potential targets for colorectal cancer prevention.Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.Is resistant starch protective against colorectal cancer via modulation of the WNT signalling pathway?

P2860

Q21245755-79770BB8-48E7-4F8B-B5CA-2671B0789369 Q22306433-A016175A-ABCA-4B05-8D51-90B94F2662AB Q24598813-190FF20E-5790-4589-84E1-79F980FF3638 Q24620457-AEA389FC-F2EE-4284-ACAA-6EEC00AD0A55 Q26749127-C7564AB3-F0C1-46CD-82AD-D04A1B949E85 Q26797207-B4D32037-B96A-4BA5-B8DF-D123D42F1BFF Q26864015-FC9EAD08-1482-489B-B954-BBD0B5371E34 Q27000363-80405058-A329-4BCD-8BBD-A52B54705937 Q27023845-4E62EB06-1D9E-4512-AB77-262688F69BFD Q28087427-F4602500-54C0-491A-B1A7-B9C3EF469800 Q28393278-F7BF99EC-42A8-4232-A952-E8C56882F09A Q28540528-744414AD-CED5-49DA-BC29-3873591878B5 Q30541685-DB26A21F-8A73-43FB-A781-D5FF7DE3633D Q33957824-87D12BF0-AC5E-4DE5-87F2-D5179699BC2E Q34075478-3CF00DDB-7FEA-44AA-8E04-3A2E3E7F6886 Q34170508-D48827D7-FF27-445B-A033-68BEE5BD13E5 Q34292368-3A665010-0E9A-4C71-A789-F7CA02CD5755 Q34656802-3FBAA4BF-0421-4F69-951C-D99EDDFB312E Q34797536-47A84AE3-73EA-4C18-A8DF-F9E324E323F8 Q34992425-187A0F2B-3E7A-44A6-879C-BD2A52DFF1D0 Q35627411-BA57056C-380C-4559-90A1-A8892237E2B3 Q35910146-67D49865-758F-484E-88AE-90B1956F011B Q35963300-B1EA6343-16E8-4B79-985C-E00855F2EFE4 Q35967304-529BDCC8-E527-4FB5-A783-83DC5DEABB2B Q36148182-8775A9DA-2F33-48B6-9E20-5BC6D8426E11 Q36152333-640B9997-BB37-4DFA-A89A-60CD5EB12D39 Q36294966-6D20CFEA-B6DE-406B-9B8B-717AE26E0382 Q36336831-608C9EAA-74F5-4E27-8C02-6EE501E9AB53 Q36381490-B448228C-6357-4F65-9466-4C37991DDA41 Q36701908-2485262B-6792-4AC1-8F1D-87C01316E7BF Q36715105-0D44C352-E501-4421-A0C6-CD34C2A0954C Q37003382-2EDE1543-B7ED-4F54-840A-CD9C2B3A1850 Q37139174-F2422B45-2D54-4FE6-B86F-B1A417C6F9FC Q37231983-7F0CBF99-23BA-4A9A-AD3E-8B4BFDD85C13 Q37277350-55DEA3B2-1AAB-4E8F-8773-A2A69A60ECCA Q37607632-D207CB3B-8D11-4D92-ADBC-78B0609BF2F5 Q38101281-02E76D87-C34F-4FF9-91B3-F159B0E62672 Q38131401-981352AC-4CF3-459D-9E73-42152E3EBCA7 Q38321114-5FB9ED3E-D53E-4879-B44E-D9CF58FD1C4A Q38361952-D15896FE-76F1-4A94-BC5B-75AC16396EA0

P2860

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

http://www.wikidata.org/entity/Q34974010

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@ast

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@en

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@en-gb

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@nl

type

label

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@ast

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@en

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@en-gb

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@nl

prefLabel

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@ast

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@en

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@en-gb

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@nl

P1433

Q34974010-A110373A-B211-44A3-A455-9BD75A9595E6

P1476

Q34974010-930B42DC-376B-46D0-8F80-2EA390D7B305

P2093

Q34974010-450236EE-4DAA-4167-98DA-1E4BCFC290ED

Q34974010-7A0CF681-9ADB-46A3-993E-3BAFB2A3F5E0

Q34974010-844B02BE-3B03-4A63-A518-59CFFA0A2E49

Q34974010-9048E5E2-6FEB-4DAF-B16D-B19D84816664

Q34974010-99DE648A-7BE3-4654-8C2A-230839535A5B

Q34974010-B7DF2E70-A905-4DC9-B2A5-1C1A1EE8A979

Q34974010-B7F45E80-43AC-4E7E-AE3D-4E2C4FB1EAB4

Q34974010-BCDA908C-57B1-4510-9115-C5CC7C4983F6

Q34974010-DE3561AC-4C6E-4C3A-8E25-D39165D02CB7

P2860

Q34974010-06944B2B-003D-400D-849F-46E797535D04

Q34974010-0ABEBD05-91E8-4F30-A832-527AE3CCBF3B

Q34974010-14F95A8F-7965-4969-B60D-B96E7F9CA8A7

Q34974010-1DBC3807-C069-4CBD-A34E-9E75512F75D1

Q34974010-1E09407F-03DE-416D-BD34-D11DFA19E6CA

Q34974010-1F4FE983-0D79-451B-A538-1C08A1A9938A

Q34974010-22AFD98E-BD00-460A-8B55-EC4B9BF89EC5

Q34974010-325B30BE-D392-495A-A3AC-D03E9E0E91B7

Q34974010-3AAAC646-93D8-4400-9771-1E5BA335C945

Q34974010-3F2ECF94-A975-4FA2-B0A8-34B776903C42

P304

Q34974010-9D43FC5C-8F7D-4C19-9746-03145E53817F

P31

Q34974010-94CF699D-2939-42E7-8073-3F49B29A0BCC

P356

Q34974010-24A51556-AFC1-4685-BCDE-2D24CC0C48D8

P433

Q34974010-2F5E8CDF-8170-4724-A9B7-3F7C3524C863

P478

Q34974010-D784D328-61BC-45CE-918C-41583AD8AE9B

P50

Q34974010-05458635-4B1C-4A6A-BA30-E0D51BACB836

Q34974010-076719DC-0B60-47FB-B3A4-1672127A2761

Q34974010-1F8DB9F5-EEE1-4B49-AB44-6667086B2AAB

Q34974010-30D9DDE1-462D-4BD3-A570-247CFA16B048

Q34974010-38629495-DEA5-4172-8765-03B34C74A7F3

Q34974010-3FFC3948-CC71-4F67-8FE0-DAA50ED27CE3

Q34974010-43AECF54-7DFA-4306-BBAD-C7D7280239EE

Q34974010-BD5AD6EE-AC24-47FB-BCD5-CB7894523D1F

Q34974010-DCE4E86E-EC92-4B0F-AF12-852AF8F1BCB7

Q34974010-E2EB42AD-8B8E-403B-9BCF-AC93018B4CE3

P577

Q34974010-EC8A29AD-E89B-463E-81FB-20FEEDDBF73A

P698

Q34974010-A97E0602-1B1F-46AC-94CD-14FBA047B18B

P921

Q34974010-6B13E714-2CB8-44AD-97A7-67560C981564

Q34974010-D749911D-9681-4097-80FF-33D9DF09C6B0

P932

Q34974010-B37B33DE-29B5-4E58-886C-B484BE752C56

P356

1940-6207.CAPR-11-0106

P1433

Cancer Prevention Research

P1476

A randomized placebo-controlle ...... amilial adenomatous polyposis.

@en

P2093

Anthony Ellis

http://www.w3.org/2001/XMLSchema#string

Faye Elliott

http://www.w3.org/2001/XMLSchema#string

Gabriela Möslein

http://www.w3.org/2001/XMLSchema#string

Hans F A Vasen

http://www.w3.org/2001/XMLSchema#string

International CAPP consortium

http://www.w3.org/2001/XMLSchema#string

Julie Coaker

http://www.w3.org/2001/XMLSchema#string

Pamela D Chapman

http://www.w3.org/2001/XMLSchema#string

Robin K S Phillips

http://www.w3.org/2001/XMLSchema#string

Steffen Bülow

http://www.w3.org/2001/XMLSchema#string

P2860

Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

Nucleolar sequestration of RelA (p65) regulates NF-kappaB-driven transcription and apoptosis

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

A randomized trial of aspirin to prevent colorectal adenomas

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial

Celecoxib for the prevention of sporadic colorectal adenomas

Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism

Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study

Nutritional implications of resistant starch

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

P304

655-665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-11-0106

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Malcolm G. Dunlop

John C. Mathers

Gabriela Möslein

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21543343

http://www.w3.org/2001/XMLSchema#string

P921

P932

3092423

http://www.w3.org/2001/XMLSchema#string